Inaugural R&D Day
Monday, September 26, 2022 10:00 am to 12:30 pm EDT
Midtown, New York City
Latest Financial Results
Q2 2023
Quarter Ended Dec 31, 2022
Latest Annual Filing
For Fiscal Year Ending Jun 30, 2022
Report Links
Email Alerts
Receive updates straight into your inbox
Latest Presentation
Cannabis associated ED visits are frequent and rapidly growing
Number of annual cannabis associated emergency department visits in the United States, 2006-2018
Note: Between 21% and 23% of all emergency department visits were captured by the National Emergency Department Sample (NEDS) in the years 2006-2014. The number of visits outside of the NEDS sample was extrapolated. Source for 2006-2014: Shen, J. J., Shan, G., Kim, P. C., Yoo, J. W., Dodge-Francis, C., & Lee, Y.-J. (2018). Trends and Related Factors of Cannabis-Associated Emergency Department Visits in the United States. Journal of Addiction Medicine, 1. doi:10.1097/adm.0000000000000479, Source for 2015-2018: Company analysis of NEDS database
Marijuana legalization is increasing
IR Contacts
Company
Anebulo Pharmaceuticals, Inc.
1415 Ranch Road 620 South
Austin, TX 78734
T: 512-598-0931
ir@anebulo.com
Investor Relations
Scott L. Anderson
T: (858) 229-7063
scott@anebulo.com
Madison Damour
madison@anebulo.com
Transfer Agent
Continental Stock Transfer & Trust Company
17 Battery Place
8th Floor
New York, NY 10004